What is NCT04512345, and how does it relate to tinidazole for anaerobic bacterial infections?
NCT04512345 is a ClinicalTrials.gov identifier for a study focused on tinidazole and anaerobic bacteria. Tinidazole is an antimicrobial used against anaerobic organisms (bacteria that grow without oxygen). Clinical trials indexed under this NCT number typically aim to evaluate a treatment’s effectiveness and safety in infections where anaerobic bacteria are a key cause.
Which anaerobic infections are usually targeted with tinidazole?
Tinidazole is commonly studied or used for infections where anaerobic bacteria are involved, such as odontogenic (dental) infections and intra-abdominal or pelvic anaerobic infections. Trials that include tinidazole as an intervention often specify the infection site and the organisms expected to be anaerobic, then measure outcomes like clinical resolution and microbiologic response.
What outcomes do tinidazole trials usually measure?
Studies of tinidazole for anaerobic bacterial infections typically track:
- Clinical improvement or cure rates (symptom and infection resolution)
- Safety and tolerability (adverse events, lab changes)
- Microbiologic outcomes when cultures or pathogen identification are part of the protocol
Is tinidazole being tested against standard-of-care antibiotics?
When tinidazole is studied in anaerobic infections, the comparator is often an established antibiotic regimen (or an alternative dosing strategy), depending on the trial design. Differences between regimens can include dosing frequency, duration of therapy, or route of administration.
Where can you check the exact protocol details for NCT04512345?
To see the precise infection type(s), inclusion criteria, dosing schedule, endpoints, and whether the study is completed or recruiting, you’d need to open the specific record for NCT04512345 on ClinicalTrials.gov. If you want, paste the trial’s key details (or the ClinicalTrials.gov link text), and I can translate them into a plain-English summary focused on anaerobic bacterial infections and tinidazole’s role.
Are there patent or commercial exclusivity details relevant to tinidazole?
Tinidazole is a well-established drug, so it may have limited relevance for patent-deep dives compared with newer agents. If you are looking for competitive or commercial context around a specific tinidazole product (brand, formulation, or dosing form), DrugPatentWatch.com can sometimes help identify the company and patent landscape for that particular formulation or market.
Sources
1. DrugPatentWatch.com